|
|
||||||||
The Journal of Thoracic and Cardiovascular Surgery, Vol 104, 684-687, Copyright © 1992 by The American Association for Thoracic Surgery and The Western Thoracic Surgical Association
FM Lupinetti, DM Behrendt, RH Giller, ME Trigg and P de Alarcon
Recipients of bone marrow transplants for hematologic malignancies are at
risk for a variety of infectious complications. We have reviewed our
experience with six patients 2 to 15 years of age who developed significant
fungal infections of the lungs before or after bone marrow transplant. No
patient was known to have active fungal or bacterial infection at the time
bone marrow transplant was performed. In two patients fungal infections
were diagnosed before bone marrow transplant, and operations were performed
to permit bone marrow transplant under optimal conditions. Four patients
had pulmonary mycoses discovered after bone marrow transplant, and
underwent operation 12 to 24 days following transplant. Operations
consisted of lobectomy (three), multiple unilateral wedge resections (one),
staged segmentectomy and contralateral wedge resection (one), and staged
bilateral wedge resection (one). Survival following bone marrow transplant
was achieved for 6 months and 11 months in patients undergoing lung
resection before transplant, and for 24, 30, 39, and 60 days in patients
undergoing lung resections after transplant. Bone marrow transplant
recipients are at high risk of pulmonary mycoses, and a vigorous search for
occult fungal infections should be carried out before transplant.
Aggressive operative treatment of fungal infections of the lungs combined
with antifungal chemotherapy before transplant may offer the best hope of
extended survival.
ARTICLES
Pulmonary resection for fungal infection in children undergoing bone marrow transplantation
Department of Surgery, University of Iowa School of Medicine, Iowa City.
This article has been cited by other articles:
![]() |
D. Gossot, P. Validire, R. Vaillancourt, G. Socie, H. Esperou, A. Devergie, P. Guardiola, D. Grunenwald, E. Gluckman, and P. Ribaud Full thoracoscopic approach for surgical management of invasive pulmonary aspergillosis Ann. Thorac. Surg., January 1, 2002; 73(1): 240 - 244. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. M. Sullivan, C. A. Dykewicz, D. L. Longworth, M. Boeckh, L. R. Baden, R. H. Rubin, and K. A. Sepkowitz Preventing Opportunistic Infections After Hematopoietic Stem Cell Transplantation: The Centers for Disease Control and Prevention, Infectious Diseases Society of America, and American Society for Blood and Marrow Transplantation Practice Guidelines and Beyond Hematology, January 1, 2001; 2001(1): 392 - 421. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. T. Salerno, D. W. Ouyang, T. S. Pederson, D. M. Larson, J. P. Shake, E. M. Johnson, and M. A. Maddaus Surgical Therapy for Pulmonary Aspergillosis in Immunocompromised Patients Ann. Thorac. Surg., May 1, 1998; 65(5): 1415 - 1419. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Bernard, D. Caillot, J. F. Couaillier, O. Casasnovas, H. Guy, and J. P. Favre Surgical Management of Invasive Pulmonary Aspergillosis in Neutropenic Patients Ann. Thorac. Surg., November 1, 1997; 64(5): 1441 - 1447. [Abstract] [Full Text] |
||||
![]() |
J. M. Habicht, A. Gratwohl, M. Tamm, J. Drewe, M. Proske, and P. Stulz DIAGNOSTIC AND THERAPEUTIC THORACIC SURGERY IN LEUKEMIA AND SEVERE APLASTIC ANEMIA J. Thorac. Cardiovasc. Surg., June 1, 1997; 113(6): 982 - 988. [Abstract] [Full Text] |
||||
![]() |
L. A. Robinson, E. C. Reed, T. A. Galbraith, A. Alonso, A. L. Moulton, and W. H. Fleming Pulmonary resection for invasive Aspergillus infections in immunocompromised patients J. Thorac. Cardiovasc. Surg., June 1, 1995; 109(6): 1182 - 1197. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |